Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials

Lung cancer is the most fatal malignancy worldwide, in part, due to high resistance to cytotoxic therapy. There is need for effective chemo-radio-sensitizers in lung cancer. In recent years, we began to understand the modulation of metabolism in cancer and its importance in tumor progression and sur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Troncone, Michael, Cargnelli, Stephanie M., Villani, Linda A., Isfahanian, Naghmeh, Broadfield, Lindsay A., Zychla, Laura, Wright, Jim, Pond, Gregory, Steinberg, Gregory R., Tsakiridis, Theodoros
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5593680/
https://ncbi.nlm.nih.gov/pubmed/28915708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.17496
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados